SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Statement Re: Press Comment

20 Nov 2008 15:32

RNS Number : 6088I
Marwyn Materials Limited
20 November 2008
 



Marwyn Materials Limited ("Marwyn Materials")

STATEMENT REGARDING 

Ennstone PLC ("Ennstone")

Further to recent speculation, Marwyn Materials confirms that it has made an approach to the board of Ennstone in order to explore a possible transaction which may or may not be an offer. 

Shareholders should be aware that there is no certainty that any transaction will occur and a further announcement will be made as and when appropriate.

For the purposes of Rule 2.10 of the City Code on Takeovers and Mergers, Marwyn Materials confirms that it has 136,000,000 ordinary shares of no par value in issue at the close of business on 19 November 2008. The ISIN reference for these securities is JE00B2419D89.

Enquiries:

For further information, please contact:

Marwyn Materials Limited

Peter Tom

020 7389 6800

Simon Vivian

020 7389 6800

Collins Stewart Europe Limited (Nominated Adviser)

Stewart Wallace, Lorraine Delannoy

020 7523 8350

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Marwyn Materials or of Ennstone all dealings in any relevant securities of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Marwyn Materials or of Ennstone, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Marwyn Materials or of Ennstone by Marwyn Materials or Ennstone, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCFGMZMKGGGRZM
Date   Source Headline
30th Apr 20132:45 pmRNSHolding(s) in Company
30th Apr 20132:09 pmRNSHolding(s) in Company
30th Apr 20137:00 amRNSUpdate on the Proposed Acquisition
26th Apr 201312:07 pmRNSResult of EGM
19th Apr 20133:45 pmRNSResult of AGM
19th Apr 20137:00 amRNSAGM Statement
12th Apr 20137:00 amRNSAgrees Acquisition of Assets from Marshalls PLC
10th Apr 20139:05 amRNSProposed Placing to fund Acquisitions
5th Mar 20137:00 amRNSFinal Results
12th Feb 20137:00 amRNSTrading Statement
8th Jan 20137:00 amRNSExercise of Warrants
6th Dec 20123:23 pmRNSTotal Voting Rights
30th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Nov 20127:00 amRNSTrading Statement
26th Oct 20127:00 amRNSBlock Listing Application
15th Oct 20127:00 amRNSProposed disposal of assets by Tarmac & Lafarge
4th Oct 20126:06 pmRNSExercise of Options
1st Aug 20123:16 pmRNSHolding(s) in Company
19th Jul 20127:00 amRNSInterim Results
11th Jul 20122:47 pmRNSHolding(s) in Company
5th Jul 20123:32 pmRNSIssue of Equity
28th Jun 201212:50 pmRNSAnnual Financial Report
1st May 20122:57 pmRNSCompetition Commission report on joint venture
25th Apr 20122:22 pmRNSHolding(s) in Company
25th Apr 201211:10 amRNSHolding(s) in Company
24th Apr 20123:45 pmRNSHolding(s) in Company
20th Apr 20123:03 pmRNSResult of AGM
20th Apr 201211:31 amRNSAGM Statement
11th Apr 20127:00 amRNSProposed Placing
6th Mar 20127:00 amRNSFinal Results
22nd Feb 20124:45 pmRNSHolding(s) in Company
17th Jan 20127:00 amRNSAcquisition
1st Dec 20117:00 amRNSTrading Statement
6th Oct 20117:00 amRNSAnalysts Visit
21st Sep 20117:00 amRNSDirector/PDMR Shareholding
9th Aug 20117:00 amRNSDirector/PDMR Shareholding
29th Jul 20112:50 pmRNSDirector/PDMR Shareholding - Replacement
29th Jul 201111:45 amRNSDirector/PDMR Shareholding
22nd Jul 20117:00 amRNSAcquisition
22nd Jul 20117:00 amRNSInterim Results
3rd Jun 201111:37 amRNSExercise of Warrants and PDMR
23rd May 20113:37 pmRNSResult of AGM
23rd May 20112:58 pmRNSTrading Statement
30th Mar 20117:00 amRNSFinal Results
12th Jan 20117:00 amRNSTrading Statement
24th Nov 20104:31 pmRNSDirector/PDMR Shareholding
10th Nov 20103:06 pmRNSIssue of Equity
26th Oct 20107:00 amRNSDirectorate Change
26th Oct 20107:00 amRNSDirectorate Change
6th Oct 20107:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.